# Caffeine, CYPA12 and Resistance Training

> **NCT06610123** · NA · COMPLETED · sponsor: **University of Alcala** · enrollment: 48 (actual)

## Conditions studied

- CYP1A2 Polymorphism
- Caffeine and Resistance Training

## Interventions

- **DIETARY_SUPPLEMENT:** Caffeine and Resistance training
- **DIETARY_SUPPLEMENT:** Placebo and Resistance training

## Key facts

- **NCT ID:** NCT06610123
- **Lead sponsor:** University of Alcala
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06610123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06610123, "Caffeine, CYPA12 and Resistance Training". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06610123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*